NMRA
NASDAQ · Pharmaceuticals
Neumora Therapeutics Inc
$1.51
-0.02 (-1.31%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+1,048.3% upside
Low Target
$11.85
Average Target
$17.34
High Target
$21.76
Current Price
$1.51
Current
$1.51
$1.51
Target
$17.34
$17.34
$11.85
$17.34 avg
$21.76
Scenario Analysis
Bear Case
$11.85
684.8%
Low target
Base Case
$17.34
+1,048.3%
Avg target
Bull Case
$21.76
+1,341.1%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$3.65
-58.6% from high
52-Week Low
$0.72
+111.0% from low
Target vs 52W High
$17.34
+375.1% vs high
Peer Consensus — Pharmaceuticals